Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06296498 · ClinicalTrials.gov registry record · NA
Application of L-PRF in Periodontal Surgery
A NA study of Periodontal Diseases, sponsored by The University of Texas Health Science Center at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT06296498: Completed NA study of Periodontal Diseases, sponsored by The University of Texas Health Science Center at San Antonio.
NCT06296498 is a NA study of Periodontal Diseases that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 21 participants, below the 160-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06296498, a NA study of Periodontal Diseases, has completed, sponsored by The University of Texas Health Science Center at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will compare the clinical outcomes of the two procedures, open flap debridement (OFD) compared to open flap debridement with leukocyte and platelet-rich fibrin (L-PFR) as well as differences in patient postoperative pain perception.
Primary Outcome
Depth of gingival pocket
Conditions Studied
Interventions
- PROCEDURE Leukocyte Platelet-rich fibrin
- OTHER Standard of care OFD
Study Locations (1)
Texas
- The University of Texas Health Science Center at San Antonio - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2023-08-19 |
| Est. Completion | 2025-12-16 |
| Phase | NA |
What the finished NCT06296498 record still lists
NCT06296498 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 160-participant average among 15 other Periodontal Diseases trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Periodontal Diseases appearing as the primary indexed condition, and to 2 interventions - of which Leukocyte Platelet-rich fibrin is the first listed.
NCT06296498 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06296498 about?
NCT06296498 is a clinical study titled "Application of L-PRF in Periodontal Surgery". The study will compare the clinical outcomes of the two procedures, open flap debridement (OFD) compared to open flap debridement with leukocyte and platelet-rich fibrin (L-PFR) as well as differences in patient postoperative pain perception.
What is the current status of trial NCT06296498?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2023-08-19. Estimated completion is 2025-12-16.
What conditions does trial NCT06296498 study?
This clinical trial studies the following conditions: Periodontal Diseases.
What interventions are being tested in trial NCT06296498?
The interventions under investigation include: Leukocyte Platelet-rich fibrin (PROCEDURE), Standard of care OFD (OTHER).
Who is sponsoring clinical trial NCT06296498?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06296498 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Periodontal Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06296498's enrollment target sits among peer trials
21 14th of 15 higher than 2 of 15 other Periodontal Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Periodontal Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel Dental Gel as an Adjunct to Scaling and Root Planing
RECRUITING · NA
-
Oral Health Intervention in Adult Primary Care
RECRUITING · NA
-
An Evaluation of the Effect of the Erchonia FX-405 Laser as an Adjunctive Treatment of Periodontitis
RECRUITING · NA
-
F.L.O.S.S. Project (Facilitated Lessons on Oral and Systemic Health in Survivors)
RECRUITING · NA
-
Microsurgery and Periodontal Healing
RECRUITING · NA
-
Addition of Dehydrated Human Amnion-Chorion Membrane During Scaling and Root Planing
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI